Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Small Cell Lung Cancer Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04958993
What this trial is testing

A Trial of Anlotinib Combined With Concurrent Chemoradiotherapy in Patients With Unresectable Stage III Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shandong Cancer Hospital and Institute 7
Testing effectiveness (Phase 2)Study completedNCT00492206
What this trial is testing

Study of Cetuximab With Radiation Followed by Consolidation Chemotherapy for NSCLC

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
University of Pittsburgh 40
Testing effectiveness (Phase 2)Ended earlyNCT00343187
What this trial is testing

A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related Rash

Who this might be right for
RashNon-small-Cell Lung Cancer
Allergan 2
Testing effectiveness (Phase 2)Study completedNCT01294306
What this trial is testing

MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy

Who this might be right for
Adenosquamous Lung CarcinomaBronchioloalveolar CarcinomaLarge Cell Lung Carcinoma+3 more
National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Looking for participantsNCT06424067
What this trial is testing

Phase 2 Study of Fingolimod in Lung Cancers

Who this might be right for
Non Small Cell Lung CancerSmall-cell Lung Cancer
Medical University of South Carolina 38
Very early researchStudy completedNCT04298606
What this trial is testing

A Vaccine (CIMAvax-EGF) for the Prevention of Lung Cancer Development or Recurrence

Who this might be right for
Chronic Obstructive Pulmonary DiseaseLung Non-Small Cell CarcinomaPneumonia+5 more
Roswell Park Cancer Institute 20
Early research (Phase 1)Study completedNCT00330044
What this trial is testing

Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer

Who this might be right for
Inoperable Non Small Cell Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 18
Testing effectiveness (Phase 2)Ended earlyNCT00503971
What this trial is testing

Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.

Who this might be right for
Non-small Cell Lung Cancer
Spanish Lung Cancer Group 33
Testing effectiveness (Phase 2)Looking for participantsNCT05940532
What this trial is testing

A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hunan Cancer Hospital 41
Early research (Phase 1)Study completedNCT00575393
What this trial is testing

Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Mayo Clinic 17
Early research (Phase 1)Active Not RecruitingNCT04141644
What this trial is testing

Safety and Efficacy of Combination Osimertinib and Ipilimumab in Patients w EGFR Mutated NSCLC

Who this might be right for
Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder)
University of Utah 24
Not applicableLooking for participantsNCT07806604
What this trial is testing

Real World Study of Icotinib in Adjuvant Post Surgical Treatment for Stage IA2 High Risk to IB EGFR Mutant Non Small Cell Lung Cancer

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Betta Pharmaceuticals Co., Ltd. 2,572
Large-scale testing (Phase 3)Ended earlyNCT04619433
What this trial is testing

Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.

Who this might be right for
Non-squamous Non-small-cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 48
Large-scale testing (Phase 3)Study completedNCT04716933
What this trial is testing

Safety and Efficacy Study of Pemetrexed + Platinum Chemotherapy + Pembrolizumab (MK-3475) With or Without Lenvatinib (MK-7902/E7080) as First-line Intervention in Adults With Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-7902-006/E7080-G000-315/LEAP-006)-China Extension Study

Who this might be right for
Nonsquamous Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 201
Testing effectiveness (Phase 2)Active Not RecruitingNCT03137771
What this trial is testing

Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
NRG Oncology 218
Early research (Phase 1)Ended earlyNCT02987998
What this trial is testing

Neoadjuvant Chemoradiation Plus Pembrolizumab Followed By Consolidation Pembrolizumab in NSCLC

Who this might be right for
Stage IIIA Non-Small Cell Lung Cancer
Nathan Pennell, MD, PhD 9
Large-scale testing (Phase 3)Looking for participantsNCT07154706
What this trial is testing

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Nuvation Bio Inc. 180
Not applicableStudy completedNCT00900328
What this trial is testing

Study of Tumor Samples From Patients With Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 280
Early research (Phase 1)Study completedNCT02897765
What this trial is testing

A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer

Who this might be right for
Urinary Bladder CancerBladder TumorsTransitional Cell Carcinoma of the Bladder+5 more
BioNTech US Inc. 34
Early research (Phase 1)Study completedNCT01837329
What this trial is testing

Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
University of Rochester 26
Next Page